The long-term objective of this research program is to determine how progestins modulate gene expression with emphasis on the mechanism of action of progesterone receptors (PRs) in regulating gene transcription. Two isoforms of PR have previously been identified: A- and B-receptors. We have recently identified a third progesterone receptor, termed the C- receptor. Based on mRNA mapping studies, the C-receptor lacks the N- terminus and the first DNA binding finger of A- and B-receptors, but contains the second DNA-binding finger, the hormone binding domain, the nuclear localization signal, and sequences for dimerization. Since the C-receptor lacks the first DNA-binding finger, we predict it does not bind DNA and, by itself, would be transcriptionally inactive. Our working hypothesis is that C-receptors negatively modulate progestin action by dimerization with active A- and B-receptors.
Aim #1 is to determine if C-transcripts are translated and if utilization of the start-site (Met 595) in the human PR cDNA results in the synthesis of C- receptors. This will be accomplished by using hybrid-selection and generating synthetic C-receptors in an in vitro transcription-translation system.
Aim #2 is to determine the interactions of C-receptors with A- or B-proteins and assess its effects on the transcriptional activity of A- and B-receptors. This will be done by analyzing the different isoforms contained in dimers identified using antibody co-precipitation techniques and gel retardation assays. The transactivational capacity of A-and B-receptors in the presence of C-receptors will be assessed in transfection studies.
Aim #3 is to determine the presence of C-receptors in progestin-responsive cells and tissues. this will be accomplished by analyzing cells or tissues for the presence of C-specific mRNA transcripts and C-receptor proteins. We will also determine whether levels of the C-receptor in breast cancer tumors are of clinical value and if so, develop a C-receptor assay.
Aim #4 will determine if the antiprogestins, RU486, ZR112, and ZR98, alter C-receptor properties.
Aim #5 is to determine if C-receptors are hormonally regulated, if C- receptors are phosphorylated (as A- and B-receptors) and determine the role of phosphorylation in C-receptor function. These studies should provide valuable information on mechanisms affecting progestin regulation of breast cancer cell growth and may lead to development of a useful marker in the treatment of breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA040011-11
Application #
6102216
Study Section
Project Start
1995-08-01
Project End
1998-07-31
Budget Start
Budget End
Support Year
11
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Pennsylvania State University
Department
Type
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Hurst, Douglas R; Welch, Danny R (2007) A MSC-ing link in metastasis? Nat Med 13:1289-91
Manni, A; Wechter, R; Verderame, M F et al. (1998) Cooperativity between the polyamine pathway and HER-2neu in transformation of human mammary epithelial cells in culture: role of the MAPK pathway. Int J Cancer 76:563-70
Phillips, K K; White, A E; Hicks, D J et al. (1998) Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Mol Carcinog 21:111-20
McGary, C T; Pan, Y C; Michel, H et al. (1997) Elevated expression of the neutrophil calcium-binding protein, MRP-14, in metastasis-enhancing neutrophils. Anticancer Res 17:1-6
Masamura, S; Santner, S J; Gimotty, P et al. (1997) Mechanism for maintenance of high breast tumor estradiol concentrations in the absence of ovarian function: role of very high affinity tissue uptake. Breast Cancer Res Treat 42:215-26
Manni, A; Wechter, R; Gilmour, S et al. (1997) Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells. Int J Cancer 70:175-82
Welch, D R (1997) Technical considerations for studying cancer metastasis in vivo. Clin Exp Metastasis 15:272-306
Wei, L L; Norris, B M; Baker, C J (1997) An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding. J Steroid Biochem Mol Biol 62:287-97
Phillips, K K; Welch, D R; Miele, M E et al. (1996) Suppression of MDA-MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer Res 56:1222-7
Manni, A; Buckwalter, E; Etindi, R et al. (1996) Induction of a less aggressive breast cancer phenotype by protein kinase C-alpha and -beta overexpression. Cell Growth Differ 7:1187-98

Showing the most recent 10 out of 96 publications